Published in Eur J Clin Pharmacol on June 28, 2008
Influence of CYP3A5 genotype on the pharmacokinetics and pharmacodynamics of the cytochrome P4503A probes alfentanil and midazolam. Clin Pharmacol Ther (2007) 0.99
Effect of propiverine on cytochrome P450 enzymes: a cocktail interaction study in healthy volunteers. Drug Metab Dispos (2005) 0.87
CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med (2006) 22.76
How well do patients take oral penicillin? A collaborative study in private practice. Pediatrics (1967) 5.82
Sp1 elements protect a CpG island from de novo methylation. Nature (1994) 5.60
A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet (2001) 5.06
Death due to bioterrorism-related inhalational anthrax: report of 2 patients. JAMA (2001) 3.55
Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor. Cancer Res (1997) 3.55
Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc Natl Acad Sci U S A (1997) 2.88
Characterization of Pseudomonas aeruginosa-induced MDCK cell injury: glycosylation-defective host cells are resistant to bacterial killing. Infect Immun (1995) 2.48
Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation. J Med Genet (2004) 2.40
Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar epithelial injury. Am J Physiol (1994) 2.33
The PKD1 gene produces a developmentally regulated protein in mesenchyme and vasculature. Nat Med (1995) 2.30
Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice. Infect Immun (2001) 1.75
Plasma 4beta-hydroxycholesterol: an endogenous CYP3A metric? Clin Pharmacol Ther (2009) 1.66
Alveolar epithelial injury and pleural empyema in acute P. aeruginosa pneumonia in anesthetized rabbits. J Appl Physiol (1985) (1993) 1.64
Hypoxaemia in children with severe pneumonia in Papua New Guinea. Int J Tuberc Lung Dis (2001) 1.57
Escalation to weekly dosing recaptures response in adalimumab-treated patients with moderately to severely active ulcerative colitis. Aliment Pharmacol Ther (2014) 1.56
Experience with percutaneous dilational tracheostomy. Ann Otol Rhinol Laryngol (2000) 1.56
The IPL gene on chromosome 11p15.5 is imprinted in humans and mice and is similar to TDAG51, implicated in Fas expression and apoptosis. Hum Mol Genet (1997) 1.56
Intestinal perforation associated with cytomegalovirus infection in patients with acquired immune deficiency syndrome. Am J Gastroenterol (1984) 1.54
Pharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools deans of education. Pharmacogenomics J (2005) 1.53
Interpersonal influences in adolescent drug use--the role of older siblings, parents, and peers. Int J Addict (1986) 1.53
Localization of specific mRNAs in Xenopus embryos by whole-mount in situ hybridization. Development (1990) 1.52
Risk of sudden infant death syndrome among infants with in utero exposure to cocaine. J Pediatr (1988) 1.49
Fatal case due to methicillin-resistant Staphylococcus aureus small colony variants in an AIDS patient. Emerg Infect Dis (1999) 1.48
Staphylococcus lugdunensis: report of a case of peritonitis and an easy-to-perform screening strategy. J Clin Microbiol (1998) 1.48
Prevention of transfusion-associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood. Transfusion (1992) 1.47
Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II. Acta Crystallogr D Biol Crystallogr (2000) 1.47
Analysis of prepro-alpha-lytic protease expression in Escherichia coli reveals that the pro region is required for activity. J Bacteriol (1989) 1.45
Bioelectrical impedance analysis in HIV-infected patients treated with triple antiretroviral treatment. Am J Clin Nutr (1999) 1.42
Development of a new G-CSF product based on biosimilarity assessment. Ann Oncol (2009) 1.41
[Vaccination against rabies: how and when?]. Dtsch Med Wochenschr (2012) 1.41
Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge: evidence for receptor-specific serotonergic dysregulation in depressed mood. Neuropsychopharmacology (2002) 1.40
Postnatal management of antenatal hydronephrosis. BJU Int (2002) 1.39
Management of myasthenia gravis. J Assoc Physicians India (1991) 1.39
Pharmacokinetics and pharmacodynamics of moist inhalation epinephrine using a mobile inhaler. Eur J Clin Pharmacol (2013) 1.35
IMPT1, an imprinted gene similar to polyspecific transporter and multi-drug resistance genes. Hum Mol Genet (1998) 1.35
Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis. Neurology (2005) 1.34
Pharmacokinetics of inhaled anaesthetics in a clinical setting: comparison of desflurane, isoflurane and sevoflurane. Br J Anaesth (2000) 1.33
Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the "cocktail" approach. Clin Pharmacol Ther (2007) 1.29
Age as a risk factor for severe manifestations and fatal outcome of falciparum malaria in European patients: observations from TropNetEurop and SIMPID Surveillance Data. Clin Infect Dis (2003) 1.29
Effect of in vitro DNA methylation on beta-globin gene expression. Proc Natl Acad Sci U S A (1988) 1.29
Production and secretion of high levels of recombinant human acetylcholinesterase in cultured cell lines: microheterogeneity of the catalytic subunit. Gene (1992) 1.28
A powerful DNA extraction method and PCR for detection of microsporidia in clinical stool specimens. Clin Diagn Lab Immunol (1999) 1.26
Factors influencing pharmacokinetics of prophylactic posaconazole in patients undergoing allogeneic stem cell transplantation. Antimicrob Agents Chemother (2009) 1.24
One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2. Aliment Pharmacol Ther (2012) 1.24
Vimentin is a novel AKT1 target mediating motility and invasion. Oncogene (2010) 1.23
Effect of an antiretroviral regimen containing ritonavir boosted lopinavir on intestinal and hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected patients. Clin Pharmacol Ther (2008) 1.23
Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test. Pharmacogenetics (1999) 1.23
Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation. Psychopharmacology (Berl) (1999) 1.22
The clinical role of genetic polymorphisms in drug-metabolizing enzymes. Pharmacogenomics J (2007) 1.21
Detection of microsporidia (Enterocytozoon bieneusi) in intestinal biopsy specimens from human immunodeficiency virus-infected patients by PCR. J Clin Microbiol (1995) 1.21
Karyometry in the early detection and chemoprevention of intraepithelial lesions. Eur J Cancer (2005) 1.20
Pharmacokinetics of inhaled anaesthetics in a clinical setting: description of a novel method based on routine monitoring data. Br J Anaesth (2000) 1.20
Dosing accuracy of commonly used disposable insulin pens. Curr Med Res Opin (2010) 1.20
Humoral and cellular immune responses of seronegative children vaccinated with a cold-adapted influenza A/HK/123/77 (H1N1) recombinant virus. Infect Immun (1980) 1.19
Competition between noggin and bone morphogenetic protein 4 activities may regulate dorsalization during Xenopus development. Proc Natl Acad Sci U S A (1995) 1.15
Evaluation of probe drugs and pharmacokinetic metrics for CYP2D6 phenotyping. Eur J Clin Pharmacol (2007) 1.14
Acetylcholinesterase peripheral anionic site degeneracy conferred by amino acid arrays sharing a common core. J Biol Chem (1994) 1.14
CMV-antigenemia in peripheral blood for the diagnosis of CMV disease in HIV-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.14
Clinical outcome of HIV-infected patients with discordant virological and immunological response to antiretroviral therapy. J Infect Dis (2010) 1.11
The effect of elimination of intersubunit disulfide bonds on the activity, assembly, and secretion of recombinant human acetylcholinesterase. Expression of acetylcholinesterase Cys-580----Ala mutant. J Biol Chem (1991) 1.10
[SARS--Severe Acute Respiratory syndrome]. Pneumologie (2003) 1.09
The generation and characterization of a cell line derived from a sporadic renal angiomyolipoma: use of telomerase to obtain stable populations of cells from benign neoplasms. Am J Pathol (2001) 1.08
Ciprofloxacin absorption in different regions of the human gastrointestinal tract. Investigations with the hf-capsule. Br J Clin Pharmacol (1990) 1.08
Detection of microsporidia in travelers with diarrhea. J Clin Microbiol (2001) 1.07
XMeis3 protein activity is required for proper hindbrain patterning in Xenopus laevis embryos. Development (2001) 1.07
Combination therapy of disseminated Fusarium oxysporum infection with terbinafine and amphotericin B. Ann Hematol (2003) 1.07
Atrial fibrillation after bypass surgery: does the arrhythmia or the characteristics of the patients prolong hospital stay? Chest (1998) 1.06
Pharmacokinetic/pharmacodynamic modeling of biomarker response to sunitinib in healthy volunteers. Clin Pharmacol Ther (2010) 1.06
Smac mimetics: implications for enhancement of targeted therapies in leukemia. Leukemia (2010) 1.05
Paraxial-fated mesoderm is required for neural crest induction in Xenopus embryos. Dev Biol (1998) 1.05
Paradoxical expansion of intracranial tuberculomas during chemotherapy. J Infect (1997) 1.05
Genetic evidence for the transcriptional-activating function of Homothorax during adult fly development. Development (2001) 1.02
Comparative biological responses of rabbits infected with human T-lymphotropic virus type I isolates from patients with lymphoproliferative and neurodegenerative disease. Int J Cancer (1992) 1.02
Allosteric modulation of acetylcholinesterase activity by peripheral ligands involves a conformational transition of the anionic subsite. Biochemistry (1995) 1.00
Pharmacokinetic and pharmacodynamic analysis of efavirenz dose reduction using an in vitro-in vivo extrapolation model. Clin Pharmacol Ther (2012) 1.00
Immunologically confirmed disseminated, asymptomatic Encephalitozoon cuniculi infection of the gastrointestinal tract in a patient with AIDS. Clin Infect Dis (1995) 0.99
Characterization and mixed infections of three strains of vaccinia virus: wild type, IBT-resistant and IBT-dependent mutants. J Gen Virol (1973) 0.99
A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study. HIV Med (2010) 0.98
Preferential upregulation of interferon-alpha subtype 2 expression in HIV-1 patients. AIDS Res Hum Retroviruses (2009) 0.98
Ras-mediated FGF signaling is required for the formation of posterior but not anterior neural tissue in Xenopus laevis. Dev Biol (2000) 0.98
Varieties of long-term outcome among patients in psychoanalysis and long-term psychotherapy. A review of findings in the Stockholm Outcome of Psychoanalysis and Psychotherapy Project (STOPP). Int J Psychoanal (2000) 0.98
Expression of the hyaluronan receptor RHAMM in endometrial carcinomas suggests a role in tumour progression and metastasis. J Cancer Res Clin Oncol (2003) 0.97
Analysis of factors affecting outcome after hepatectomy of patients with liver cirrhosis and small hepatocellular carcinoma. Eur J Surg (1998) 0.97
Interaction of quinolones with the theophylline metabolism in man: investigations with lomefloxacin and pipemidic acid. Int J Clin Pharmacol Ther Toxicol (1989) 0.97